3 Viktökning Dosberoende viktökning observerades i de kliniska studierna med pioglitazon, vilket kan bero på ansamling av fett och i vissa fall vätskeretention. ###>Weight gain In clinical trials with pioglitazone there was evidence of dose related weight gain, which may be due to fat accumulation and in some cases associated with fluid retention.